Oligosaccharides

<p>5-O-β-D-Glucopyranosyl-D-xylitol is a disaccharide that is synthesized for use in research.</p>

<p>Lacto-N-difucohexaose IV is a pentasaccharide with a lacto-n-difucohexaose backbone that has been shown to have inhibitory activities against human red blood cells. This pentasaccharide is a glycosaminoglycan, which is a type of carbohydrate that consists of an oligosaccharide and protein. Lacto-N-difucohexaose IV specifically binds to the antigen on the surface of human red blood cells, inhibiting their proliferation. The pentasaccharide is also known as Hansson's hapten or Hapten IV. The pentasaccharides are found in group O blood and are not found in groups A, B, or AB.</p>

<p>Glycyl-sialyllacto-N-tetraose c is a custom synthesis of the carbohydrate polysaccharide glycyl-sialyllacto-N-tetraose. It is a complex carbohydrate that has been modified for use in biochemical research. Glycyl-sialyllacto-N-tetraose c contains four sugars, including erythrose and threose, and has been fluorinated at the C5 position. The modification of this carbohydrate was achieved through a click reaction. This product has been purified to be greater than 95% pure and is ready for use as an organic solvent or chemical reagent in laboratory experiments.</p>

<p>Lacto-N-triose I is a carbohydrate antigen that is used as an acceptor in the synthesis of trisaccharides. Lacto-N-triose I has been shown to have acidic hydrolysis and gel permeation chromatography. It can be used for the synthesis of oligosaccharides, which are important for glycosylation reactions. Lacto-N-triose I also has a glycosylation reaction that can be activated by desulfurization.</p>

<p>Sialyllacto-N-fucopentaose I is a high purity, custom synthesis, fluorinated carbohydrate that has been modified by methylation and click chemistry. This oligosaccharide is composed of a saccharide with a molecular weight of 908.5 g/mol and an enantiomeric purity of 99%. Sialyllacto-N-fucopentaose I is an Oligosaccharide with a CAS number of 61497-04-8. It is used in the synthesis of polysaccharides or as a monosaccharide or sugar substitute to produce high purity products.</p>

This mixture contains some of the lower oligosaccharides found in human milk. There are small amounts of lactose but the bulk of the mixture are tri- and tetrasaccharides. 3-Fucosyllactose, 3'-Sialyllactose, 6'-Sialyllactose, Lacto-N-tetraose, Sialyllacto-N-tetraose b, Sialyllacto-N-tetraose b and Blood Group A tetrasaccharide type V are the major components that have been found in the mixture by chromatography but there may be other minor components not mentioned here.

GQ3 oligosaccharide is the carbohydrate moiety in the GQ3 ganglioside. Breast cancer cells MCF-7 were found to express a complex pattern of neutral and sialylated glycosphingolipids from the globo- and ganglio-series, including unusual tetrasialylated and pentasialylated lactosylceramide derivatives, and GQ3 (II3Neu5Ac4-Gg2Cer) (Steenackers, 2012).

<p>Applications N,N’,N’’-Triacetyl Chitotriose is a multivalent glycosides with strong crosslinking activity for lectin as a specific coagulant.<br>References Bhattacharyya, L., et al.: Biochemistry, 29, 7523 (1990), Sacchettini, J., et al.: Biochemistry, 40, 3009 (2001), Maierhofer, C., et al.: Bioorg. Med. Chem., 15, 7661 (2007),<br></p>

Neutral octasasaccharide naturally present in human breast milk.

2-Acetamido-3-O-(b-D-galactopyranosyl)-2-deoxy-D-thiogalactopyranose is a synthetic disaccharide analog designed for research in glycoscience and biochemistry, particularly for applications in glycosylation-related studies. This compound is synthesized in the laboratory and is not derived from natural sources, allowing for precise structural modifications that facilitate detailed analyses of glycan interactions.The mode of action of this compound involves its role as a mimic of natural glycans, enabling the examination of carbohydrate-protein interactions, enzymatic activity, and glycan recognition processes with high specificity. It can be leveraged as a probe in structural biology to elucidate the mechanisms underlying biological recognition and signaling events mediated by carbohydrate molecules.This compound finds applications in the study of enzymatic hydrolysis, as an inhibitor of glycosidases, and in the synthesis of glycan-based drugs. It is of particular interest in the field of glycobiology for developing therapeutic agents and probing molecular pathways. The high specificity and structural fidelity of 2-Acetamido-3-O-(b-D-galactopyranosyl)-2-deoxy-D-thiogalactopyranose make it an invaluable tool for advancing our understanding of the intricate roles glycans play in biology.

Lewis Y tetrasaccharide is a type of antigen that is used as a pharmacological agent. It has been shown to be effective in treating carcinoma cell lines and primary sclerosing cholangitis. Lewis Y tetrasaccharide has also been shown to be an antigen for the mouse monoclonal antibody, which is used in cancer research. The Lewis Y tetrasaccharide stimulates the immune system by interacting with certain cells called dendritic cells and macrophages, which are responsible for activating T-cells. This interaction promotes the production of chemoattractant proteins, which are proteins that attract white blood cells to fight infection and promote healing. Lewis Y tetrasaccharide has also been shown to cause cancer cell death by lysing cells through apoptosis or necrosis depending on the tissue type.

Drug carrier for cancer therapy & imaging, biocompatible, soluble, biodegradable

Emulsifier used in the cosmetic industry

<p>Occurs by epimerisation of maltose and transglucosylation</p>

<p>Tetrasaccharide; tumor-associated antigen; prognostic factor</p>

1-Deoxy-1-morpholino-D-fructose is a drug that has been shown to have an inhibitory effect on the production of dinitrophenol, leading to a decrease in the level of reactive oxygen species. The drug binds to lysine residues of proteins and forms adducts with physiological function. 1-Deoxy-1-morpholino-D-fructose also inhibits human serum albumin concentration, which may be due to its ability to inhibit oxidative DNA damage. This drug has been shown to be effective in vivo for treating autoimmune diseases and diabetes.